ARCHIVES

In Brief: Christopher Walsh Named Dana-Farber President; Sachs Leaves NCI; Acoustic Neuroma Conference

This article is from The Cancer Letter archive.

Vol. 17 No. 33 | August 16, 1991

Download PDF Visit The Full Archive

Related Articles

Two Regorafenib Trials Demonstrate Efficacy, Improve Overall and Progression-Free Survival

December 28, 2012

In Brief: Tormey To Replace Carbone As ECOG chairman; Bishop Delivers First B.J. Kennedy Lecture

November 2, 1990

In Congress: Bills Seek Medicare Coverage for Patients In Cancer Clinical Trials

April 23, 1999

Costs of Rosenberg Regimen Could Hinder cooperative Group Trials

January 3, 1986

Upton Says He’s Still Undecided About Leaving NCI

September 28, 1979

Regulations Threaten Clinical Trials Higgins contends

May 16, 1980